The SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already taking metformin. The primary aim was ...

The move has public health circles abuzz, and a caveat has since been filed in the Supreme Court on the matter, said S.Srinivasan, with the All India Drug Action Network (Aidan) - appellants in the ca ...

From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side ...

Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category. Mounjaro, manufactured by Lilly, ...

Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind ...

The biopharmaceutical company released phase three clinical data for its type two diabetes treatment ecnoglutide in the peer-reviewed scientific journal.

A. Metformin has long been a first-line medication for Type 2 diabetes, but it is certainly not the only drug that can help ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s ...

Metformin has been prescribed for decades. Most people associate the drug with blood sugar control and type 2 diabetes. This misses a much larger conversation now happening in aging research and ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...